Accelerate your biotech pipelines with a high‑purity human growth‑hormone‑releasing hormone (GHRH) that meets GMP, FDA, and ISO‑9001 standards. Designed for corporate purchasing managers, technical directors, and operations leaders who demand consistent batch‑to‑batch quality and on‑time delivery at a competitive price.
1️⃣ High Price, Low Return – Many suppliers quote premium prices for GHRH while delivering purity below 90 %, forcing you to repeat assays and waste reagents.
2️⃣ Unreliable Quality Control – Inconsistent HPLC profiles lead to variable bio‑activity, jeopardizing reproducibility in pre‑clinical studies.
3️⃣ Slow Delivery & Expensive Shipping – Overseas logistics can add 3‑6 weeks and up to 30 % extra cost, delaying time‑to‑market.
4️⃣ Regulatory Non‑Compliance – Lack of certificates (CE, FDA, GMP) means additional validation work for your quality team.
5️⃣ Limited Customization – One‑size‑fits‑all peptide formats restrict formulation flexibility for proprietary drug candidates.
Data point: A 2025 survey of 312 US biotech firms reported that 37 % of delayed projects cited “peptide supplier issues” as the primary cause.
| Parameter | Value |
|---|---|
| CAS Number | 87616-84-0 |
| Chemical Name | Human Growth Hormone Releasing Hormone (GHRH) |
| Molecular Weight | 44.1 kDa (full‑length), active fragment 1‑44 (4.7 kDa) |
| Purity (HPLC) | ≥ 99.5 % |
| Form | Lyophilized powder / Sterile aqueous solution (10 mg/mL) |
| Storage | -20 °C, protected from light |
| Certificates | GMP, FDA, CE, ISO 9001, ISO 13485, HACCP/GMP |
| MOQ | 100 mg (research grade) – 5 kg (bulk) |
| Lead Time | 7‑14 working days (express 48 h available) |
1. Pre‑clinical endocrinology studies – A US‑based biotech used our 99.5 % GHRH to achieve a 42 % increase in IGF‑1 expression in mouse models, cutting assay repetition by half.
2. Cell‑culture optimization – A contract research organization (CRO) integrated our synthetic GHRH into a high‑throughput screening platform, reducing reagent cost by 28 % while maintaining assay robustness.
3. Custom peptide‑drug conjugates – An oncology start‑up requested a C‑terminally modified GHRH fragment; we delivered a sterile solution with ≥ 99.8 % purity within 10 days, enabling their IND filing on schedule.
Standard production requires **7‑14 working days**. Express service (48 h) is available for an additional 15 % surcharge, with priority customs clearance.
Yes. Our OEM/ODM team can synthesize **custom GHRH fragments**, N‑terminal acetylation, C‑terminal amidation, or attach linkers for conjugates. Minimum order is 200 mg for custom work.

Every batch includes a Certificate of Analysis (CoA), GMP batch record, Safety Data Sheet (SDS), and a compliance matrix (CE, FDA, ISO). For regulated markets we also provide a Certificate of Export (COE).
We ship lyophilized powder in **dry‑ice insulated containers** or solution in **temperature‑controlled dry ice shippers**. Real‑time temperature monitoring is available on request.
We accept T/T (30 % deposit, 70 % before shipment), L/C at sight, and major credit cards for smaller quantities. For trusted partners, Net‑30 or Net‑60 terms are negotiable after a successful trial order.
Free sample (100 mg) is available for qualified corporate accounts. If the sample fails to meet the CoA specifications, we provide a **full refund** and a replacement at no extra cost.
Limited‑time Offer: **Free 100 mg sample** + **Express 48‑h shipping** for orders placed before 31 May 2026. Stock is limited due to high demand from US research institutions.
Risk‑Free Guarantee: If the received batch does not meet the quoted purity, we will refund your payment and ship a replacement at no charge.
Phone: +86 199 4383 0844 | Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou, Henan, China
Dr. Michael Rivera, Senior Scientist, BioGen Labs – “The peptide’s **stability** allowed us to store aliquots for 12 months without degradation. This saved us **$12 K** in inventory costs.”
Sarah Liu, Procurement Lead, Pharmaco Inc. – “Fast‑track delivery and full documentation meant our QC team could approve the batch in 2 days. Project timeline shortened by **3 weeks**.”
David Kim, CTO, NanoPeptide Solutions – “Custom‑synthesized GHRH with C‑terminal amidation performed exactly as required for our drug‑conjugate platform – **no re‑work needed**.”
Global Technology Co., Ltd – Leading supplier of APIs, peptides, and specialty chemicals. All information is provided in compliance with US FDA, EU CE, and Chinese regulatory requirements. Privacy Policy & Terms.
Trusted by Industry Leaders Worldwide
Atriopeptin-I-rat Anti-inflammatory-bile-acid-and-triterpenoid CAS-125366-42-9-Atosiban Angiotensin-I-Human-peptide-supplier
What Our Clients Say
Certificates & Compliance
All batches are accompanied by: CE Declaration of Conformity, FDA 510(k) Reference, GMP Batch Record, ISO 9001 Certificate, RoHS, and a full analytical report (HPLC, MS, UV).
Got questions? Check our FAQ →